Toggle Nav
My Cart
Search
Menu
Account
Settings
Healthcare

Strategic Analysis of Indian Biosimilar Market

 

INDUSTRY
Healthcare

RELEASE DATE
10-May-2011
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P43E-01-00-00-00
SKU
HC02321-AP-MR_08313
Yes
SHARE

Strategic Analysis of Indian Biosimilar Market
Published on: 10-May-2011 | SKU: HC02321-AP-MR_08313

Need more details?
$4,950.00
DownloadLink
Request Sample
Add to Compare
Need more details?
Description

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.

Table of Contents

Brief Summary of Indian Biosimilar Market

  • Executive Summary of the Biosimilar market
  • Future Impact

Overview of Global Biosimilar Market

  • Introduction to Biosimilars
  • Global Population Demographics
  • Key Biodrugs
  • Types of Products Manufactured by Major Participants
  • Market Size of Biosimilars: Global
  • Market Size: Biologic Patents Expiring in 2011-2016
  • Market Size: Biologics Patents Expiring 2016-2019
  • Market Size : Worldwide Sales of Key Biodrugs
  • Market Opportunities
  • Market Size of Biosimilars: Revenue Forecasts
  • Major Participants - Global
  • Major Participants - Trends

Overview if Indian Biosimilar Market

  • Overview of Indian Biosimilar Market
  • Timeline of Indian Market
  • Indian Market Portfolio
  • Domestic Market Potential
  • Market Drivers Ranked in Order of Impact
  • General Factors favoring the market
  • Market Restraints Ranked in Order of Impact
  • Hurdles faced by Indian Participants
  • Domestic Market Potential - Observed Trends in Market
  • Export Potential - Overview
  • Export Potential - Expansion Strategy of Indian Participants
  • Overview of Highly Regulated Markets: Europe
  • Overview of Highly Regulated Markets: The United States
  • Overview of Semi-regulated Markets: China
  • Cost Advantage of India
  • Biosimilar Market in India: Revenue Forecasts

Overview of Regulatory Scenario

  • Indian Regulations for Biosimilars
  • International Regulatory Authorities European Medicines Agency (EMA)
  • International Regulatory Authorities US-FDA

Overview of Major Participants in the Indian Market

  • Biocon
  • Dr. Reddy’s
  • Ranbaxy
  • Wockhardt
  • Intas Biopharmaceuticals
  • Shantha Biotech

Overview of Historical trends and Future Impact

  • 2001-2010: A Historical View of the Biosimilar Market
  • 2010-2015: Frost & Sullivan View on the Biosimilars Market

Overview of Chinese Biosimilar Market

  • Overview of Biosimilar Market in China
  • China – Major Participants

Frost and Sullivan: Overview

  • Who is Frost and Sullivan
  • What makes us unique
  • T.E.A.M. Methodology
  • Global Perspective
Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

23 Oct 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.